Robert Rouder (US)

Subscribe to all posts by Robert Rouder (US)

Amarin and FDA settle off-label suit

As we reported last August, U.S. District Judge Paul Engelmayer ruled that Amarin Pharma has a First Amendment right to truthfully promote its prescription drug Vascepa for off-label uses. August 10, 2015, article.  Shortly afterward, Amarin and the government entered settlement talks.  August 31, 2015 update. We are now able to report that on March … Continue reading
LexBlog